The content on this site is intended for healthcare professionals only
Prof Josep Tabernero, Vall d'Hebron Institute of Oncology, Barcelona, Spain, talks to ecancer Managing Editor Prof Gordon McVie about research he presented at the 2011 European Multidisciplinary Cancer Conference, Stockholm. Results From VELOUR, a Phase III Study of Aflibercept (A) Versus Placebo (pbo) in Combination with FOLFIRI for the Treatment of Patients with Previously Treated Metastatic Colorectal Cancer (MCRC). FOL – folinic acid (leucovorin), F – fluorouracil (5-FU) and IRI – irinotecan.
Post-diagnosis diet, nutrition and cancer prognosis
WCI's role in the prevention of tobacco related cancer among Beedi rolling women in India
Alternative livelihood training programme for rural women who are employed in the tobacco industry in India
Selecting patients wisely for neoadjuvant therapy in HPB cancers
ESMO 2024: Highlights and analysis
Mutational-based treatment approach may significantly improve outcomes in pretreated patients with metastatic solid tumours
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies
Assessment of suicide risk in cancer patients
Cancer journeys: Research from India
